Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace R Macklin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Infectious Diseases|August 11, 2020
Final frontiers of the polio eradication endgameAnanda S Bandyopadhyay, Grace R Macklin
The Lancet. Infectious Diseases|July 28, 2019
Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysisGrace R Macklin, Nicholas C Grassly, Roland W Sutter, et al.
Vaccine|August 25, 2022
Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020Grace R Macklin, Ajay K Goel, Ondrej Mach, et al.
Vaccine|March 21, 2022
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experienceGrace R Macklin, Corey Peak, Martin Eisenhawer, et al.
The Lancet. Global Health|November 18, 2022
Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021Azamdzhon Mirzoev, Grace R Macklin, Yiting Zhang, et al.
The Lancet. Global Health|May 18, 2023
Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence surveyStephen B Kennedy, Grace R Macklin, Gloria Mason Ross, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Infectious Diseases|August 11, 2020
Final frontiers of the polio eradication endgameAnanda S Bandyopadhyay, Grace R Macklin
The Lancet. Infectious Diseases|July 28, 2019
Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysisGrace R Macklin, Nicholas C Grassly, Roland W Sutter, et al.
Vaccine|August 25, 2022
Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020Grace R Macklin, Ajay K Goel, Ondrej Mach, et al.
Vaccine|March 21, 2022
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experienceGrace R Macklin, Corey Peak, Martin Eisenhawer, et al.
The Lancet. Global Health|November 18, 2022
Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021Azamdzhon Mirzoev, Grace R Macklin, Yiting Zhang, et al.
The Lancet. Global Health|May 18, 2023
Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence surveyStephen B Kennedy, Grace R Macklin, Gloria Mason Ross, et al.
Pageof 1